randomized trial final analysis of the Intergroupe Francophone du Myélome 9502 cell transplantation in patients with newly diagnosed multiple myeloma: melphalan as conditioning regimens for peripheral blood stem 2 140 mg/m melphalan and 8 Gy total body irradiation plus 2 Comparison of 200 mg/m